Cerebral Embolic Protection Devices: Are There Any Indications in Transcatheter Aortic Valve Replacement?

Area of Science:

• Cardiovascular Surgery
• Neurology
• Biomedical Engineering

Background:

• Stroke is a critical complication of transcatheter aortic valve replacement (TAVR).
• Cerebral embolic events are a primary cause of stroke during or shortly after TAVR.
• Silent ischemic brain injuries are common during TAVR procedures.

Purpose of the Study:

• To review the use of cerebral embolic protection devices (CEPDs) in TAVR patients.
• To analyze the clinical efficacy of CEPDs in mitigating peri-procedural stroke.
• To discuss future perspectives and clinical implications of CEPD use in TAVR.

Main Methods:

• Comprehensive literature review on CEPD utilization in TAVR.
• Analysis of existing studies on the impact of CEPDs on silent ischemic brain injuries.
• Exploration of clinical trial data and real-world evidence regarding CEPD effectiveness.

Main Results:

• CEPDs are designed to reduce intraprocedural cerebral embolic burden during TAVR.
• Current evidence on the clinical efficacy of CEPDs in preventing stroke post-TAVR is uncertain.
• The impact of CEPDs on reducing new silent ischemic brain injuries requires further investigation.

Conclusions:

• CEPDs represent a technological advancement aimed at improving TAVR safety by reducing stroke risk.
• Further research is essential to establish the definitive role and clinical benefit of CEPDs in TAVR.
• Understanding the long-term implications of CEPD use is crucial for optimizing TAVR patient outcomes.